{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:30:06Z","timestamp":1773480606790,"version":"3.50.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12035-021-02326-9","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:21:10Z","timestamp":1613780470000},"page":"3031-3042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of Liver Growth Factor (LGF) in Parkinson\u2019s Disease: Molecular Insights and Therapeutic Opportunities"],"prefix":"10.1007","volume":"58","author":[{"given":"Efthalia","family":"Angelopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yam Nath","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-0618","authenticated-orcid":false,"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"issue":"16","key":"2326_CR1","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1503\/cmaj.151179","volume":"188","author":"P Rizek","year":"2016","unstructured":"Rizek P, Kumar N, Jog MS (2016) An update on the diagnosis and treatment of Parkinson disease. CMAJ 188(16):1157\u20131165","journal-title":"CMAJ"},{"key":"2326_CR2","doi-asserted-by":"crossref","unstructured":"Angelopoulou E et al (2020) Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson's disease: Molecular mechanisms connecting neuroinflammation to alpha-synuclein spreading pathology. Biology (Basel):9(4)","DOI":"10.3390\/biology9040086"},{"key":"2326_CR3","doi-asserted-by":"publisher","first-page":"104930","DOI":"10.1016\/j.phrs.2020.104930","volume":"158","author":"E Angelopoulou","year":"2020","unstructured":"Angelopoulou E, Paudel YN, Shaikh MF, Piperi C (2020) Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications. Pharmacol Res 158:104930","journal-title":"Pharmacol Res"},{"key":"2326_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu I, Bennett SAL (2019) Dysregulated lipid metabolism and its role in alpha-synucleinopathy in Parkinson's disease. Front Neurosci 13:328","journal-title":"Front Neurosci"},{"issue":"6","key":"2326_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-010-9523-y","volume":"30","author":"Y Yuan","year":"2010","unstructured":"Yuan Y, Sun J, Zhao M, Hu J, Wang X, du G, Chen NH (2010) Overexpression of alpha-synuclein down-regulates BDNF expression. Cell Mol Neurobiol 30(6):939\u2013946","journal-title":"Cell Mol Neurobiol"},{"key":"2326_CR6","doi-asserted-by":"crossref","unstructured":"Palasz, E., et al., BDNF as a promising therapeutic agent in Parkinson's disease. Int J Mol Sci, 2020. 21(3).","DOI":"10.3390\/ijms21031170"},{"key":"2326_CR7","doi-asserted-by":"crossref","unstructured":"Ziebell, M., et al., Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration. Neurobiol Aging, 2012. 33(2): p. 428 e1\u20135.","DOI":"10.1016\/j.neurobiolaging.2010.11.010"},{"issue":"4","key":"2326_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4103\/1673-5374.205084","volume":"12","author":"TB Sampaio","year":"2017","unstructured":"Sampaio TB, Savall AS, Gutierrez MEZ, Pinton S (2017) Neurotrophic factors in Alzheimer's and Parkinson's diseases: Implications for pathogenesis and therapy. Neural Regen Res 12(4):549\u2013557","journal-title":"Neural Regen Res"},{"issue":"4","key":"2326_CR9","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.neuroscience.2010.10.010","volume":"171","author":"N Nevalainen","year":"2010","unstructured":"Nevalainen N, Chermenina M, Rehnmark A, Bergl\u00f6f E, Marschinke F, Str\u00f6mberg I (2010) Glial cell line-derived neurotrophic factor is crucial for long-term maintenance of the nigrostriatal system. Neuroscience 171(4):1357\u20131366","journal-title":"Neuroscience"},{"issue":"7149","key":"2326_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature05957","volume":"448","author":"P Lindholm","year":"2007","unstructured":"Lindholm P, Voutilainen MH, Laur\u00e9n J, Per\u00e4nen J, Lepp\u00e4nen VM, Andressoo JO, Lindahl M, Janhunen S et al (2007) Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448(7149):73\u201377","journal-title":"Nature"},{"issue":"Pt 11","key":"2326_CR11","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/brain\/123.11.2297","volume":"123","author":"A Schrag","year":"2000","unstructured":"Schrag A, Quinn N (2000) Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 123(Pt 11):2297\u20132305","journal-title":"Brain"},{"issue":"2","key":"2326_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/1673-5374.177710","volume":"11","author":"AM Sullivan","year":"2016","unstructured":"Sullivan AM, O'Keeffe GW (2016) Neurotrophic factor therapy for Parkinson's disease: Past, present and future. Neural Regen Res 11(2):205\u2013207","journal-title":"Neural Regen Res"},{"key":"2326_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00441-020-03227-4","volume":"382","author":"AK Mahato","year":"2020","unstructured":"Mahato AK, Sidorova YA (2020) Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease. Cell Tissue Res 382:147\u2013160","journal-title":"Cell Tissue Res"},{"issue":"9","key":"2326_CR14","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1039\/C9FO01309A","volume":"10","author":"Y Yu","year":"2019","unstructured":"Yu Y, Lang XY, Li XX, Gu RZ, Liu QS, Lan R, Qin XY (2019) 2,3,5,4'-Tetrahydroxystilbene-2-O-beta-d-glucoside attenuates MPP+\/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis. Food Funct 10(9):6009\u20136019","journal-title":"Food Funct"},{"key":"2326_CR15","doi-asserted-by":"publisher","first-page":"963689720908512","DOI":"10.1177\/0963689720908512","volume":"29","author":"S Sun","year":"2020","unstructured":"Sun S et al (2020) GDNF promotes survival and therapeutic efficacy of human adipose-derived mesenchymal stem cells in a mouse model of Parkinson's disease. Cell Transplant 29:963689720908512","journal-title":"Cell Transplant"},{"issue":"11","key":"2326_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188239","volume":"12","author":"D Reyes-Corona","year":"2017","unstructured":"Reyes-Corona D, V\u00e1zquez-Hern\u00e1ndez N, Escobedo L, Orozco-Barrios CE, Ayala-Davila J, Moreno MG, Amaro-Lara ME, Flores-Martinez YM et al (2017) Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion. PLoS One 12(11):e0188239","journal-title":"PLoS One"},{"issue":"9","key":"2326_CR17","first-page":"699","volume":"44","author":"S Singh","year":"2006","unstructured":"Singh S, Ahmad R, Mathur D, Sagar RK, Krishana B (2006) Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease. Indian J Exp Biol 44(9):699\u2013704","journal-title":"Indian J Exp Biol"},{"key":"2326_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2014.05.019","volume":"274","author":"MM Migliore","year":"2014","unstructured":"Migliore MM, Ortiz R, Dye S, Campbell RB, Amiji MM, Waszczak BL (2014) Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease. Neuroscience 274:11\u201323","journal-title":"Neuroscience"},{"issue":"13","key":"2326_CR19","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1523\/JNEUROSCI.18-13-04929.1998","volume":"18","author":"BA Horger","year":"1998","unstructured":"Horger BA, Nishimura MC, Armanini MP, Wang LC, Poulsen KT, Rosenblad C, Kirik D, Moffat B et al (1998) Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci 18(13):4929\u20134937","journal-title":"J Neurosci"},{"issue":"3","key":"2326_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/brain\/awz023","volume":"142","author":"A Whone","year":"2019","unstructured":"Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D et al (2019) Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease. Brain 142(3):512\u2013525","journal-title":"Brain"},{"issue":"12","key":"2326_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","volume":"9","author":"WJ Marks Jr","year":"2010","unstructured":"Marks WJ Jr, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M et al (2010) Gene delivery of AAV2-neurturin for Parkinson's disease: A double-blind, randomised, controlled trial. Lancet Neurol 9(12):1164\u20131172","journal-title":"Lancet Neurol"},{"issue":"1","key":"2326_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/bj2350049","volume":"235","author":"JJ Diaz-Gil","year":"1986","unstructured":"Diaz-Gil JJ et al (1986) Purification of a liver DNA-synthesis promoter from plasma of partially hepatectomized rats. Biochem J 235(1):49\u201355","journal-title":"Biochem J"},{"issue":"2","key":"2326_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/bj2430443","volume":"243","author":"JJ Diaz-Gil","year":"1987","unstructured":"Diaz-Gil JJ et al (1987) Identification of a liver growth factor as an albumin-bilirubin complex. Biochem J 243(2):443\u2013448","journal-title":"Biochem J"},{"issue":"3","key":"2326_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/1574889809666141224123303","volume":"9","author":"R Gonzalo-Gobernado","year":"2014","unstructured":"Gonzalo-Gobernado R, Calatrava-Ferreras L, Perucho J, Reimers D, Casarejos MJ, Herranz AS, Jimenez-Escrig A, Diaz-Gil JJ et al (2014) Liver growth factor as a tissue regenerating factor in neurodegenerative diseases. Recent Pat CNS Drug Discov 9(3):173\u2013180","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"5","key":"2326_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1369\/jhc.2009.952275","volume":"57","author":"R Gonzalo-Gobernado","year":"2009","unstructured":"Gonzalo-Gobernado R, Reimers D, Herranz AS, D\u00edaz-Gil JJ, Osuna C, Asensio MJ, Baena S, Rodr\u00edguez-Serrano M et al (2009) Mobilization of neural stem cells and generation of new neurons in 6-OHDA-lesioned rats by intracerebroventricular infusion of liver growth factor. J Histochem Cytochem 57(5):491\u2013502","journal-title":"J Histochem Cytochem"},{"key":"2326_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7827-9-21","volume":"9","author":"M Perez-Crespo","year":"2011","unstructured":"Perez-Crespo M et al (2011) Effect of liver growth factor on both testicular regeneration and recovery of spermatogenesis in busulfan-treated mice. Reprod Biol Endocrinol 9:21","journal-title":"Reprod Biol Endocrinol"},{"key":"2326_CR27","doi-asserted-by":"crossref","unstructured":"Calatrava-Ferreras L et al (2016) Liver growth factor (LGF) upregulates frataxin protein expression and reduces oxidative stress in Friedreich's ataxia transgenic mice. Int J Mol Sci:17(12)","DOI":"10.3390\/ijms17122066"},{"key":"2326_CR28","doi-asserted-by":"crossref","unstructured":"Gonzalo-Gobernado R et al (2020) Liver growth factor \"LGF\" as a therapeutic agent for Alzheimer's disease. Int J Mol Sci:21(23)","DOI":"10.3390\/ijms21239201"},{"issue":"7","key":"2326_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067771","volume":"8","author":"R Gonzalo-Gobernado","year":"2013","unstructured":"Gonzalo-Gobernado R, Calatrava-Ferreras L, Reimers D, Herranz AS, Rodr\u00edguez-Serrano M, Miranda C, Jim\u00e9nez-Escrig A, D\u00edaz-Gil JJ et al (2013) Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease. PLoS One 8(7):e67771","journal-title":"PLoS One"},{"key":"2326_CR30","doi-asserted-by":"crossref","unstructured":"Gonzalo-Gobernado R et al (2020) Liver growth factor induces glia-associated neuroprotection in an in vitro model of Parkinson's disease. Brain Sci:10(5)","DOI":"10.3390\/brainsci10050315"},{"issue":"4","key":"2326_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1369\/jhc.5A6805.2005","volume":"54","author":"D Reimers","year":"2006","unstructured":"Reimers D, Herranz AS, Diaz-Gil JJ, Lobo MVT, Pa\u00edno CL, Alonso R, Asensio MJ, Gonzalo-Gobernado R et al (2006) Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats. J Histochem Cytochem 54(4):457\u2013465","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"2326_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/157488812798483421","volume":"7","author":"D Reimers","year":"2012","unstructured":"Reimers D, Osuna C, Gonzalo-Gobernado R, S. Herranz A, Jose Diaz-Gil J, Jimenez-Escrig A, Jose Asensio M, Miranda C et al (2012) Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease. Curr Stem Cell Res Ther 7(1):15\u201325","journal-title":"Curr Stem Cell Res Ther"},{"key":"2326_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.06.025","volume":"56","author":"GW O'Keeffe","year":"2018","unstructured":"O'Keeffe GW, Sullivan AM (2018) Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease. Parkinsonism Relat Disord 56:9\u201315","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 8","key":"2326_CR34","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 136(Pt 8):2419\u20132431","journal-title":"Brain"},{"issue":"1","key":"2326_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/exnr.2001.7638","volume":"169","author":"B Connor","year":"2001","unstructured":"Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC (2001) Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration. Exp Neurol 169(1):83\u201395","journal-title":"Exp Neurol"},{"issue":"1","key":"2326_CR36","doi-asserted-by":"publisher","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","volume":"1","author":"K Tieu","year":"2011","unstructured":"Tieu K (2011) A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb Perspect Med 1(1):a009316","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"2326_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1006\/neur.1995.0016","volume":"4","author":"BS Jeon","year":"1995","unstructured":"Jeon BS, Jackson-Lewis V, Burke RE (1995) 6-Hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death. Neurodegeneration 4(2):131\u2013137","journal-title":"Neurodegeneration"},{"issue":"2","key":"2326_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","volume":"59","author":"H Sauer","year":"1994","unstructured":"Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59(2):401\u2013415","journal-title":"Neuroscience"},{"issue":"9","key":"2326_CR39","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jnr.21642","volume":"86","author":"I Branchi","year":"2008","unstructured":"Branchi I, D'Andrea I, Armida M, Cassano T, P\u00e8zzola A, Potenza RL, Morgese MG, Popoli P et al (2008) Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model. J Neurosci Res 86(9):2050\u20132061","journal-title":"J Neurosci Res"},{"issue":"3","key":"2326_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","volume":"67","author":"S Przedborski","year":"1995","unstructured":"Przedborski S et al (1995) Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67(3):631\u2013647","journal-title":"Neuroscience"},{"issue":"1","key":"2326_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508(1):1\u201312","journal-title":"Arch Biochem Biophys"},{"key":"2326_CR42","doi-asserted-by":"publisher","first-page":"112692","DOI":"10.1016\/j.bbr.2020.112692","volume":"392","author":"SS Bilge","year":"2020","unstructured":"Bilge SS, G\u00fcnaydin C, \u00d6nger ME, Bozkurt A, Avci B (2020) Neuroprotective action of agmatine in rotenone-induced model of Parkinson's disease: Role of BDNF\/cREB and ERK pathway. Behav Brain Res 392:112692","journal-title":"Behav Brain Res"},{"key":"2326_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cellsig.2017.06.007","volume":"37","author":"X Gu","year":"2017","unstructured":"Gu X, Liu L, Shen Q, Xing D (2017) Photoactivation of ERK\/CREB\/VMAT2 pathway attenuates MPP(+)-induced neuronal injury in a cellular model of Parkinson's disease. Cell Signal 37:103\u2013114","journal-title":"Cell Signal"},{"issue":"2","key":"2326_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbrc.2019.11.102","volume":"522","author":"Z Feng","year":"2020","unstructured":"Feng Z, Zhang L, Wang S, Hong Q (2020) Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p\/CREB pathway in Parkinson's disease. Biochem Biophys Res Commun 522(2):388\u2013394","journal-title":"Biochem Biophys Res Commun"},{"key":"2326_CR45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.brainres.2009.11.063","volume":"1313","author":"H Ralay Ranaivo","year":"2010","unstructured":"Ralay Ranaivo H, Wainwright MS (2010) Albumin activates astrocytes and microglia through mitogen-activated protein kinase pathways. Brain Res 1313:222\u2013231","journal-title":"Brain Res"},{"issue":"1","key":"2326_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1471-4159.2010.06584.x","volume":"113","author":"HT Lee","year":"2010","unstructured":"Lee HT, Chang YC, Tu YF, Huang CC (2010) CREB activation mediates VEGF-A's protection of neurons and cerebral vascular endothelial cells. J Neurochem 113(1):79\u201391","journal-title":"J Neurochem"},{"issue":"1","key":"2326_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-017-2738-1","volume":"371","author":"X Zhao","year":"2018","unstructured":"Zhao X, Moore DL (2018) Neural stem cells: Developmental mechanisms and disease modeling. Cell Tissue Res 371(1):1\u20136","journal-title":"Cell Tissue Res"},{"key":"2326_CR48","doi-asserted-by":"crossref","unstructured":"Lu Q et al (2020) Icariin sustains the proliferation and differentiation of Abeta25-35-treated hippocampal neural stem cells via the BDNF-TrkB-ERK\/Akt signaling pathway. Neurol Res:1\u201310","DOI":"10.1080\/01616412.2020.1792701"},{"issue":"5","key":"2326_CR49","first-page":"1184","volume":"24","author":"Z Dong","year":"2007","unstructured":"Dong Z, Su L, Mino J (2007) Effects of endothelial cells on renewal and differentiation of neural stem cells. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 24(5):1184\u20131186","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"issue":"5675","key":"2326_CR50","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.1095505","volume":"304","author":"Q Shen","year":"2004","unstructured":"Shen Q et al (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304(5675):1338\u20131340","journal-title":"Science"},{"issue":"1","key":"2326_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/exnr.2002.7989","volume":"177","author":"M Yang","year":"2002","unstructured":"Yang M, Stull ND, Berk MA, Snyder EY, Iacovitti L (2002) Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. Exp Neurol 177(1):50\u201360","journal-title":"Exp Neurol"},{"issue":"48","key":"2326_CR52","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1523\/JNEUROSCI.3208-04.2004","volume":"24","author":"I Liste","year":"2004","unstructured":"Liste I, Garcia-Garcia E, Martinez-Serrano A (2004) The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. J Neurosci 24(48):10786\u201310795","journal-title":"J Neurosci"},{"key":"2326_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fncel.2020.00209","volume":"14","author":"A Bernaus","year":"2020","unstructured":"Bernaus A, Blanco S, Sevilla A (2020) Glia crosstalk in neuroinflammatory diseases. Front Cell Neurosci 14:209","journal-title":"Front Cell Neurosci"},{"key":"2326_CR54","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","volume":"11","author":"H Hampel","year":"2020","unstructured":"Hampel H, Caraci F, Cuello AC, Caruso G, Nistic\u00f2 R, Corbo M, Baldacci F, Toschi N et al (2020) A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease. Front Immunol 11:456","journal-title":"Front Immunol"},{"key":"2326_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","volume":"302","author":"L Probert","year":"2015","unstructured":"Probert L (2015) TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects. Neuroscience 302:2\u201322","journal-title":"Neuroscience"},{"issue":"4","key":"2326_CR56","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson's disease. Mov Disord 23(4):474\u2013483","journal-title":"Mov Disord"},{"issue":"6","key":"2326_CR57","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1460-9568.2004.03254.x","volume":"19","author":"T Yasuhara","year":"2004","unstructured":"Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y et al (2004) Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci 19(6):1494\u20131504","journal-title":"Eur J Neurosci"},{"issue":"5","key":"2326_CR58","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999","volume":"19","author":"PE Batchelor","year":"1999","unstructured":"Batchelor PE, Liberatore GT, Wong JYF, Porritt MJ, Frerichs F, Donnan GA, Howells DW (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19(5):1708\u20131716","journal-title":"J Neurosci"},{"issue":"19","key":"2326_CR59","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1073\/pnas.0900358106","volume":"106","author":"M Cui","year":"2009","unstructured":"Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA et al (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 106(19):8043\u20138048","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2326_CR60","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/j.1471-4159.1987.tb05737.x","volume":"48","author":"Y Mizuno","year":"1987","unstructured":"Mizuno Y, Sone N, Saitoh T (1987) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem 48(6):1787\u20131793","journal-title":"J Neurochem"},{"issue":"1","key":"2326_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neulet.2004.12.073","volume":"378","author":"SG Cho","year":"2005","unstructured":"Cho SG, Yi SY, Yoo YS (2005) IFNgamma and TNFalpha synergistically induce neurite outgrowth on PC12 cells. Neurosci Lett 378(1):49\u201354","journal-title":"Neurosci Lett"},{"issue":"11","key":"2326_CR62","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/00001756-200308060-00026","volume":"14","author":"S Remy","year":"2003","unstructured":"Remy S et al (2003) Lipopolysaccharide and TNFalpha regulate the expression of GDNF, neurturin and their receptors. Neuroreport 14(11):1529\u20131534","journal-title":"Neuroreport"},{"issue":"6","key":"2326_CR63","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1096\/fj.05-5106com","volume":"20","author":"K Sriram","year":"2006","unstructured":"Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP (2006) Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: Role of TNF-alpha. FASEB J 20(6):670\u2013682","journal-title":"FASEB J"},{"key":"2326_CR64","doi-asserted-by":"crossref","unstructured":"Kuno, R., Yoshida Y., Nitta A., Nabeshima T., Wang J., Sonobe Y., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A., The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res, 2006. 1116(1): p. 12\u201318.","DOI":"10.1016\/j.brainres.2006.07.120"},{"issue":"5","key":"2326_CR65","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0168-8278(03)00030-8","volume":"38","author":"JJ Diaz-Gil","year":"2003","unstructured":"Diaz-Gil JJ et al (2003) The mitogenic activity of the liver growth factor is mediated by tumor necrosis factor alpha in rat liver. J Hepatol 38(5):598\u2013604","journal-title":"J Hepatol"},{"issue":"1","key":"2326_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","volume":"119","author":"B Desai Bradaric","year":"2012","unstructured":"Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B (2012) Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm (Vienna) 119(1):59\u201371","journal-title":"J Neural Transm (Vienna)"},{"issue":"9157","key":"2326_CR67","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","volume":"353","author":"BA Faucheux","year":"1999","unstructured":"Faucheux BA, Agid Y, Hirsch EC, Bonnet AM (1999) Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353(9157):981\u2013982","journal-title":"Lancet"},{"issue":"9","key":"2326_CR68","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00702-004-0256-2","volume":"112","author":"C Barcia","year":"2005","unstructured":"Barcia C, Bautista V, S\u00e1nchez-Bahillo \u00c1, Fern\u00e1ndez-Villalba E, Faucheux B, Poza y Poza M, Fernandez Barreiro A, Hirsch EC et al (2005) Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian. J Neural Transm (Vienna) 112(9):1237\u20131248","journal-title":"J Neural Transm (Vienna)"},{"issue":"37","key":"2326_CR69","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1523\/JNEUROSCI.0944-06.2006","volume":"26","author":"JE Westin","year":"2006","unstructured":"Westin JE, Lindgren HS, Gardi J, Nyengaard JR, Brundin P, Mohapel P, Cenci MA (2006) Endothelial proliferation and increased blood\u2013brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia. J Neurosci 26(37):9448\u20139461","journal-title":"J Neurosci"},{"issue":"21","key":"2326_CR70","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1212\/WNL.0000000000002151","volume":"85","author":"S Janelidze","year":"2015","unstructured":"Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG et al (2015) Increased CSF biomarkers of angiogenesis in Parkinson disease. Neurology 85(21):1834\u20131842","journal-title":"Neurology"},{"issue":"11","key":"2326_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112995","volume":"9","author":"A Giron-Martinez","year":"2014","unstructured":"Giron-Martinez A et al (2014) Proliferative activity of liver growth factor is associated with an improvement of cigarette smoke-induced emphysema in mice. PLoS One 9(11):e112995","journal-title":"PLoS One"},{"issue":"1","key":"2326_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","volume":"22","author":"O Hwang","year":"2013","unstructured":"Hwang O (2013) Role of oxidative stress in Parkinson's disease. Exp Neurobiol 22(1):11\u201317","journal-title":"Exp Neurobiol"},{"issue":"4","key":"2326_CR73","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","volume":"7","author":"SY Chung","year":"2016","unstructured":"Chung SY, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov EV, Puspita L, Valiulahi P et al (2016) Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and alpha-synuclein accumulation. Stem Cell Reports 7(4):664\u2013677","journal-title":"Stem Cell Reports"},{"issue":"5","key":"2326_CR74","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.freeradbiomed.2008.12.002","volume":"46","author":"L Condezo-Hoyos","year":"2009","unstructured":"Condezo-Hoyos L, Abderrahim F, Conde MV, Sus\u00edn C, D\u00edaz-Gil JJ, Gonz\u00e1lez MC, Arribas SM (2009) Antioxidant activity of liver growth factor, a bilirubin covalently bound to albumin. Free Radic Biol Med 46(5):656\u2013662","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2326_CR75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JPD-171221","volume":"8","author":"A Simitsi","year":"2018","unstructured":"Simitsi A, Koros C, Moraitou M, Papagiannakis N, Antonellou R, Bozi M, Angelopoulou E, Stamelou M et al (2018) Phenotypic characteristics in GBA-associated Parkinson's disease: A study in a Greek population. J Parkinsons Dis 8(1):101\u2013105","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"2326_CR76","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg ME, Burke D, Heales SJR, Cooper JM, Hardy J, Wood NW, Schapira AHV (2012) Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains. Ann Neurol 72(3):455\u2013463","journal-title":"Ann Neurol"},{"key":"2326_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2020.00077","volume":"11","author":"E Pepin","year":"2020","unstructured":"Pepin E et al (2020) Sphingosine-1-phosphate receptors modulators decrease signs of neuroinflammation and prevent Parkinson's disease symptoms in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model. Front Pharmacol 11:77","journal-title":"Front Pharmacol"},{"key":"2326_CR78","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2147\/CLEP.S163493","volume":"10","author":"CT Hong","year":"2018","unstructured":"Hong CT, Hu HH, Chan L, Bai CH (2018) Prevalent cerebrovascular and cardiovascular disease in people with Parkinson's disease: A meta-analysis. Clin Epidemiol 10:1147\u20131154","journal-title":"Clin Epidemiol"},{"issue":"7","key":"2326_CR79","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/mds.22013","volume":"23","author":"X Huang","year":"2008","unstructured":"Huang X, Abbott RD, Petrovitch H, Mailman RB, Ross GW (2008) Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia aging study. Mov Disord 23(7):1013\u20131018","journal-title":"Mov Disord"},{"key":"2326_CR80","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jpba.2017.02.045","volume":"139","author":"A Navarrete","year":"2017","unstructured":"Navarrete A, Rup\u00e9rez FJ, Mendes TO, P\u00e9rez-Rial S, Gir\u00f3n-Mart\u00ednez A, Terr\u00f3n-Exp\u00f3sito R, D\u00edaz-Gil JJ, Peces-Barba G et al (2017) A metabolomic approach shows sphingosine 1-phosphate and lysophospholipids as mediators of the therapeutic effect of liver growth factor in emphysema. J Pharm Biomed Anal 139:238\u2013246","journal-title":"J Pharm Biomed Anal"},{"key":"2326_CR81","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","volume":"49","author":"RM Adibhatla","year":"2008","unstructured":"Adibhatla RM, Hatcher JF (2008) Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49:241\u2013268","journal-title":"Subcell Biochem"},{"key":"2326_CR82","doi-asserted-by":"publisher","first-page":"135256","DOI":"10.1016\/j.neulet.2020.135256","volume":"736","author":"M Huang","year":"2020","unstructured":"Huang M, Wang Y, Wang L, Chen B, Wang X, Hu Y (2020) APOE rs405509 polymorphism and Parkinson's disease risk in the Chinese population. Neurosci Lett 736:135256","journal-title":"Neurosci Lett"},{"key":"2326_CR83","doi-asserted-by":"crossref","unstructured":"Davis AA et al (2020) APOE genotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med:12(529)","DOI":"10.1126\/scitranslmed.aay3069"},{"issue":"5","key":"2326_CR84","first-page":"609","volume":"25","author":"JC Surra","year":"2010","unstructured":"Surra JC, Guill\u00e9n N, Barranquero C, Arbon\u00e9s-Mainar JM, Navarro MA, Gasc\u00f3n S, Arnal C, Godino J et al (2010) Sex-dependent effect of liver growth factor on atherosclerotic lesions and fatty liver disease in apolipoprotein E knockout mice. Histol Histopathol 25(5):609\u2013618","journal-title":"Histol Histopathol"},{"issue":"1","key":"2326_CR85","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02740748","volume":"12","author":"F Blandini","year":"1996","unstructured":"Blandini F, Porter RH, Greenamyre JT (1996) Glutamate and Parkinson's disease. Mol Neurobiol 12(1):73\u201394","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2326_CR86","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","volume":"219","author":"GE Meredith","year":"2009","unstructured":"Meredith GE, Totterdell S, Beales M, Meshul CK (2009) Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Exp Neurol 219(1):334\u2013340","journal-title":"Exp Neurol"},{"key":"2326_CR87","doi-asserted-by":"publisher","first-page":"585584","DOI":"10.3389\/fnins.2020.585584","volume":"14","author":"J Wang","year":"2020","unstructured":"Wang J, Wang F, Mai D, Qu S (2020) Molecular mechanisms of glutamate toxicity in Parkinson's disease. Front Neurosci 14:585584","journal-title":"Front Neurosci"},{"issue":"10","key":"2326_CR88","doi-asserted-by":"publisher","first-page":"19056","DOI":"10.3390\/ijms151019056","volume":"15","author":"L Calatrava-Ferreras","year":"2014","unstructured":"Calatrava-Ferreras L, Gonzalo-Gobernado R, Reimers D, Herranz A, Jim\u00e9nez-Escrig A, D\u00edaz-Gil J, Casarejos M, Montero-Vega M et al (2014) Neuroprotective role of liver growth factor \"LGF\" in an experimental model of cerebellar ataxia. Int J Mol Sci 15(10):19056\u201319073","journal-title":"Int J Mol Sci"},{"key":"2326_CR89","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells. J Pharmacol Sci 144:151\u2013164","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"2326_CR90","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","volume":"235","author":"M Decressac","year":"2012","unstructured":"Decressac M, Mattsson B, Bjorklund A (2012) Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson's disease. Exp Neurol 235(1):306\u2013315","journal-title":"Exp Neurol"},{"issue":"11","key":"2326_CR91","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","volume":"39","author":"NP Visanji","year":"2016","unstructured":"Visanji NP, Brotchie JM, Kalia LV, Koprich JB, Tandon A, Watts JC, Lang AE (2016) Alpha-Synuclein-based animal models of Parkinson's disease: Challenges and opportunities in a new era. Trends Neurosci 39(11):750\u2013762","journal-title":"Trends Neurosci"},{"issue":"3","key":"2326_CR92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14802\/jmd.19046","volume":"12","author":"HK Chung","year":"2019","unstructured":"Chung HK, Ho HA, P\u00e9rez-Acu\u00f1a D, Lee SJ (2019) Modeling alpha-synuclein propagation with preformed fibril injections. J Mov Disord 12(3):139\u2013151","journal-title":"J Mov Disord"},{"issue":"1","key":"2326_CR93","doi-asserted-by":"publisher","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","volume":"7","author":"M Karampetsou","year":"2017","unstructured":"Karampetsou M, Ardah MT, Semitekolou M, Polissidis A, Samiotaki M, Kalomoiri M, Majbour N, Xanthou G et al (2017) Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice. Sci Rep 7(1):16533","journal-title":"Sci Rep"},{"issue":"3","key":"2326_CR94","first-page":"197","volume":"6","author":"JJ Diaz-Gil","year":"1989","unstructured":"Diaz-Gil JJ et al (1989) Liver growth factor purified from human plasma is an albumin\u2013bilirubin complex. Mol Biol Med 6(3):197\u2013207","journal-title":"Mol Biol Med"},{"issue":"40","key":"2326_CR95","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X, Manfredsson FP, Benskey MJ, Cao X, Xu J, Sun YE et al (2017) TrkB neurotrophic activities are blocked by alpha-synuclein, triggering dopaminergic cell death in Parkinson's disease. Proc Natl Acad Sci U S A 114(40):10773\u201310778","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2326_CR96","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.05.023","volume":"29","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu H, Zhang BS, Soares JC, Zhang XY (2016) Low BDNF is associated with cognitive impairments in patients with Parkinson's disease. Parkinsonism Relat Disord 29:66\u201371","journal-title":"Parkinsonism Relat Disord"},{"key":"2326_CR97","doi-asserted-by":"crossref","unstructured":"A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III). Neurology, 1999. 52(7): p. 1427\u201333.","DOI":"10.1212\/WNL.52.7.1427"},{"issue":"3","key":"2326_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14660820050515197","volume":"1","author":"G Ochs","year":"2000","unstructured":"Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E et al (2000) A phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(3):201\u2013206","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"4","key":"2326_CR99","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.neuroscience.2003.08.037","volume":"122","author":"S Lahteinen","year":"2003","unstructured":"Lahteinen S et al (2003) Exacerbated status epilepticus and acute cell loss, but no changes in epileptogenesis, in mice with increased brain-derived neurotrophic factor signaling. Neuroscience 122(4):1081\u20131092","journal-title":"Neuroscience"},{"issue":"2","key":"2326_CR100","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/jb\/mvw037","volume":"160","author":"K Ito","year":"2016","unstructured":"Ito K, Enomoto H (2016) Retrograde transport of neurotrophic factor signaling: Implications in neuronal development and pathogenesis. J Biochem 160(2):77\u201385","journal-title":"J Biochem"},{"key":"2326_CR101","first-page":"10","volume":"9","author":"X d\u2019Anglemont de Tassigny","year":"2015","unstructured":"d\u2019Anglemont de Tassigny X, Pascual A, Lopez-Barneo J (2015) GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease. Front Neuroanat 9:10","journal-title":"Front Neuroanat"},{"issue":"9","key":"2326_CR102","doi-asserted-by":"publisher","first-page":"L718","DOI":"10.1152\/ajplung.00293.2013","volume":"307","author":"S Perez-Rial","year":"2014","unstructured":"Perez-Rial S et al (2014) Liver growth factor treatment reverses emphysema previously established in a cigarette smoke exposure mouse model. Am J Physiol Lung Cell Mol Physiol 307(9):L718\u2013L726","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"2326_CR103","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F et al (2018) Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation 15(1):205","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2326_CR104","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1152\/physrev.00012.2005","volume":"86","author":"D Mehta","year":"2006","unstructured":"Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86(1):279\u2013367","journal-title":"Physiol Rev"},{"issue":"7","key":"2326_CR105","first-page":"1013","volume":"44","author":"PJ Thornalley","year":"1998","unstructured":"Thornalley PJ (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol (Noisy-le-grand) 44(7):1013\u20131023","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"2326_CR106","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s12035-018-1109-6","volume":"56","author":"AE Aly","year":"2019","unstructured":"Aly AE et al (2019) Intranasal delivery of pGDNF DNA nanoparticles provides neuroprotection in the rat 6-hydroxydopamine model of Parkinson's disease. Mol Neurobiol 56(1):688\u2013701","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2326_CR107","doi-asserted-by":"publisher","first-page":"19402","DOI":"10.1038\/s41598-019-55294-5","volume":"9","author":"R Ji","year":"2019","unstructured":"Ji R, Smith M, Niimi Y, Karakatsani ME, Murillo MF, Jackson-Lewis V, Przedborski S, Konofagou EE (2019) Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson's disease mouse model. Sci Rep 9(1):19402","journal-title":"Sci Rep"},{"issue":"3","key":"2326_CR108","first-page":"113","volume":"4","author":"JJ Diaz Gil","year":"1994","unstructured":"Diaz Gil JJ et al (1994) Hepatic growth induced by injection of the liver growth factor into normal rats. Growth Regul 4(3):113\u2013122","journal-title":"Growth Regul"},{"issue":"2","key":"2326_CR109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainres.2005.05.072","volume":"1052","author":"M Sun","year":"2005","unstructured":"Sun M, Kong L, Wang X, Lu XG, Gao Q, Geller AI (2005) Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. Brain Res 1052(2):119\u2013129","journal-title":"Brain Res"},{"issue":"1","key":"2326_CR110","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2005.02.009","volume":"20","author":"IG Onyango","year":"2005","unstructured":"Onyango IG, Tuttle JB, Bennett JP Jr (2005) Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death. Neurobiol Dis 20(1):141\u2013154","journal-title":"Neurobiol Dis"},{"issue":"8","key":"2326_CR111","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/mt.2013.108","volume":"21","author":"D Krakora","year":"2013","unstructured":"Krakora D, Mulcrone P, Meyer M, Lewis C, Bernau K, Gowing G, Zimprich C, Aebischer P et al (2013) Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol Ther 21(8):1602\u20131610","journal-title":"Mol Ther"},{"issue":"9","key":"2326_CR112","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/jnr.21641","volume":"86","author":"N Lindgren","year":"2008","unstructured":"Lindgren N, Leak RK, Carlson KM, Smith AD, Zigmond MJ (2008) Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease. J Neurosci Res 86(9):2039\u20132049","journal-title":"J Neurosci Res"},{"issue":"3","key":"2326_CR113","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3233\/JPD-202128","volume":"10","author":"K McFarthing","year":"2020","unstructured":"McFarthing K, Buff S, Rafaloff G, Dominey T, Wyse RK, Stott SR (2020) Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2020. J Parkinsons Dis 10(3):757\u2013774","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"2326_CR114","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/mds.26354","volume":"30","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Kalia SK, Lang AE (2015) Disease-modifying strategies for Parkinson's disease. Mov Disord 30(11):1442\u20131450","journal-title":"Mov Disord"},{"issue":"3","key":"2326_CR115","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3233\/JPD-202004","volume":"10","author":"RA Barker","year":"2020","unstructured":"Barker RA, Bj\u00f6rklund A, Gash DM, Whone A, van Laar A, Kordower JH, Bankiewicz K, Kieburtz K et al (2020) GDNF and Parkinson's disease: Where next? A summary from a recent workshop. J Parkinsons Dis 10(3):875\u2013891","journal-title":"J Parkinsons Dis"},{"key":"2326_CR116","doi-asserted-by":"crossref","unstructured":"Riboldi GM, Di Fonzo AB (2019) GBA, Gaucher disease, and Parkinson's disease: From genetic to clinic to new therapeutic approaches. Cells:8(4)","DOI":"10.3390\/cells8040364"},{"issue":"3","key":"2326_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1537","volume":"10","author":"M Michalowska","year":"2020","unstructured":"Michalowska M et al (2020) Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease. Brain Behav 10(3):e01537","journal-title":"Brain Behav"},{"issue":"8","key":"2326_CR118","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20198443","volume":"52","author":"Q Wang","year":"2019","unstructured":"Wang Q, Liu J, Guo Y, Dong G, Zou W, Chen Z (2019) Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: A meta-analysis. Braz J Med Biol Res 52(8):e8443","journal-title":"Braz J Med Biol Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02326-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02326-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02326-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T12:33:59Z","timestamp":1674995639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02326-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":118,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2326"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02326-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"19 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}